Medifocus Inc. is in the business of developing and selling medical device systems that deliver precisely focused, microwave-generated heat to diseased tissue, thereby destroying or shrinking it. The Company owns over three technology platforms. The Endo-thermotherapy Platform is a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites. The Prolieve Thermodilatation System for the treatment of Benign Prostatic Hyperplasia was developed based on the Endo-thermotherapy Platform. The Adaptive Phased Array (APA) Microwave Focusing Platform directs precisely focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. The Heat-Activated and Tumor-Targeted Immunotherapy and Gene Therapy Technology is used for the development of heat-activated and tumor-targeted immunotherapy and gene therapy for the treatment of cancers and other diseases.